trending Market Intelligence /marketintelligence/en/news-insights/trending/7xmsx6icpw864oecdb8s0g2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

VIVUS implements 1-for-10 reverse stock split

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

VIVUS implements 1-for-10 reverse stock split

VIVUS Inc. said its shareholders approved a 1-for-10 reverse stock split of the company's stock.

The biopharmaceutical company's shares will start trading on a split-adjusted basis Sept. 11.

The stock split will reduce VIVUS outstanding shares to about 10.6 million from 106 million.

Campbell, Calif.-based VIVUS develops and commercializes therapies that focus on advancing treatments for patients with serious unmet medical needs.

"We determined that the 1-for-10 ratio would position VIVUS with the appropriate liquidity associated with listing shares on a major U.S. exchange and is critical for the continued execution of our strategic plan to return VIVUS to profitability and establish a sustainable business that creates value for stockholders and patients," VIVUS CEO John Amos said in a statement.